Clerodendron glandulosum.Coleb extract ameliorates high fat diet/fatty acid induced lipotoxicity in experimental models of non-alcoholic steatohepatitis

Food and Chemical Toxicology

Volumn 48, Issue 12, 2010, Pages 3424-3431

  Jadeja, Ravirajsinh N ^a   Thounaojam, Menaka C ^a   Dandekar, Deven S ^b   Devkar, Ranjitsinh V ^a   Ramachandran, A V ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b SOLVO BIOTECHNOLOGY   (Hungary)

Author keywords

Clerodendron glandulosum .Coleb; HepG2 cells; Non alcoholic steatohepatitis; Oleic acid; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CLERODENDRON GLANDULOSUM EXTRACT; LIVER PROTECTIVE AGENT; OLEIC ACID; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL STRAIN HEPG2; CELL VIABILITY; CLERODENDRON GLANDULOSUM; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; LIPID STORAGE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; VERBENACEAE;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CELL LINE; CELL SURVIVAL; CLERODENDRUM; DIET; DIETARY FATS; FATTY ACIDS; FATTY LIVER; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES;

CLERODENDRUM; MUS;

EID: 78049451156     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.09.015     Document Type: Article

References (49)

1. Aebi H. Catalase. Methods of Enzymatic Analysis, vol. 11 1974, 673-684. Academic Press, New York. USA. H.U. Bergmeyer (Ed.).
2. Albert L.S., Kuldip G. Traditional use of medicinal plants by the Jaintia tribes in North Cachar Hills district of Assam, northeast India. J. Ethnobiol. Ethnomed. 2006, 2:33.
3. Amarapurkar D.N., Hashimoto E., Lesmana L.A., Sollano J.D., Chen P., Goh K.L. How common is non-alcoholic fatty liver disease in the Asia-Pacific region, and are there local differences?. J. Gastroenterol. Hepatol. 2007, 22:788-793.
4. Beutler E., Duron O., Kelly B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1963, 61:882-888.
5. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., Yang C.S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high fat fed mice. J. Nutr. 2008, 138:1677-1683.
6. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52:302-310.
7. Caldwell S.H., Swerdlow R.H., Khan E.M., Iezzoni J.C., Hespenheide E.E., Parks J.K., Parker W.D. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J. Hepatol. 1999, 31:430-434.
8. Calixto J.B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res. 2000, 33:179-189.
9. Chidambaram, J., Venkatraman, A.C., 2010. Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet. Food Chem. Toxicol. doi: 10.1016/j.fct.2010.04.044.
10. Chitturi S., Abeygunasekera S., Farrell G.C., Holmes-Walker J., Hui J.M., Fung C., Karim R., Lin R., Samarasinghe D., Liddle C., Weltman M., George Jacob. NASH and insulin resistance. Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373-379.
11. Cui W., Chen S.L., Hu K. Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am. J. Transl. Res. 2010, 2:95-104.
12. Dabhi A.S., Brahmbhatt K.J., Pandya T.P., Thorat P.B., Shah M.C. Non-alcoholic fatty liver disease (NAFLD). J. Ind. Acad. Clin. Med. 2008, 9:36-41.
13. Day C.P., James O. Steatohepatitis: a tale of " two hits''?. Gastroenterology 1998, 114:842-845.
14. Duvnjak M., Lerotić I., Baršić N., Tomašić V., Jukić L.V., Velagić V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J. Gastroenterol. 2007, 13:4539-4550.
15. Folch J., Lees M., Stanley S.G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.
16. Ellman G. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
17. Fromenty B., Robin M.A., Igoudjil A., Mansouri A., Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes. Metab. 2004, 30:121-138.
18. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 1995, 41:1819-1828.
19. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974, 249:7130-7139.
20. Hong X., Tang H., Wu L., Li L. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. J. Pharm. Pharmacol. 2006, 58:1391-1398.
21. Itaya K., Ui M. Colorimetric determination of free fatty acids in biological fluids. J. Lipid. Res. 1965, 6:16-20.
22. Jadeja R.N., Thounaojam M.C., Ansarullah, Devkar R.V., Ramachandran A.V. A preliminary study on hypolipidemic effect of aqueous leaf extract of Clerodendron glandulosum.Coleb. Int. J. Green Pharm. 2009, 3:285-289.
23. Jadeja R., Thounaojam M., Ansarullah, Ramachandran A.V., Devkar R. Phytochemical constituents and free radical scavenging activity of Clerodendron glandulosum.Coleb methanolic extract. J. Compl. Integr. Med. 2009, 6:19.
24. Jadeja R.N., Thounaojam M.C., Ansarullah, Devkar R.V., Ramachandran A.V. Clerodendron glandulosum Coleb. Verbenaceae, ameliorates high fat diet-induced alteration in lipid and cholesterol metabolism in rats. Revista Brasileira de Farmacognosia 2010, 20:117-123.
25. Jadeja, R.N., Thounaojam, M.C., Ansarullah, Patel, V.B., Devkar, R.V., Ramachandran, A.V., 2010b. Protective effect of Clerodendron glandulosum. extract against experimentally induced metabolic syndrome in rats. Pharm. Biol. doi: 10.3109/13880201003739304.
26. Jadeja, R.N., Thounaojam, M.C., Ansarullah., Jadav, S.V., Patel, M.D., Patel, D.K, Salunke, S.P., Padate, G.S., Devkar, R.V., Ramachandran, A.V., 2010c. Toxicological evaluation and hepatoprotective potential of Clerodendron glandulosum.Coleb leaf extract. Hum. Exp. Toxicol. doi: 10.1177/0960327110368420.
27. Janorkar A.V., King K.R., Megeed Z., Yarmush M.L. Development of an in vitro cell culture model of hepatic steatosis using hepatocyte-derived reporter cells. Biotechnol. Bioeng. 2009, 102:1466-1474.
28. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of SOD. Ind. J. Biochem. Biophys. 1984, 21:130-132.
29. Kohjima M., Enjoji M., Higuchi N., Kato M., Kotoh K., Nakashima M., Nakamuta M. The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells In Vitro. Cell Dev. Biol.-Animal. 2009, 45:6-9.
30. Koruk M., Taysi S., Savas M.C., Yilmaz O., Akcay F., Karakok M. Oxidative stress and enzymatic antioxidant status in patients with non-alcoholic steatohepatitis. Ann. Clin. Lab. Sci. 2004, 34:1.
31. Malaguarnera M., Rosa M.D., Nicoletti F., Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J. Mol. Med. 2009, 87:679-695.
32. Mishra D., Mehta A., Flora S.J.S. Reversal of arsenic-induced hepatic apoptosis with combined administration of DMSA and its analogues in Guinea Pigs: role of glutathione and linked enzymes. Chem. Res. Toxicol. 2008, 21:400-407.
33. Mohandas J., Marshall J.J., Duggin G.G., Horvath J.S., Tiller D.J. Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney: possible implications in analgesic nephropathy. Biochem. Pharmacol. 1984, 33:1801-1807.
34. Nakamoto K., Takayama F., Mankura M., Hidaka Yuki., Egashira Toru., Ogino T., Kawasaki H., Mori A. Beneficial-effects of fermented green tea extract in a rat model of non-alcoholic steatohepatitis. J. Clin. Biochem. Nutr. 2009, 44:239-246.
35. Bellentani S., Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann. Hepatol. 2009, 8:S4-S8.
36. Nourooz-zadeh J., Tajaddini-sarmadi J., Ling K.L.E., Wolff S.P. Low density lipoprotein is the major carrier of lipid hydroperoxides in plasma relevance to determination of total plasma lipid hydroperoxide concentrations. Biochem. J. 1996, 313:781-786.
37. Okamoto Y., Tanaka S., Haga Y. Enhanced GLUT2 gene expression in an oleic acid induced in vitro fatty liver model. Hepatol. Res. 2002, 23:138-144.
38. Oliveira C.P.M.S., Faintuch J., Rascovski A., Furuya C.K., Bastos M.D.S., Matsuda M., Nina B.I.D., Yahnosi K.A., Vezozzo D.C.P., Alves V.A.F., Zilberstein B., Garrido A.B., Halpern A., Carrilho F.J., Gama-Rodrigues J.J. Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) - preliminary findings. Obesity Surg. 2005, 15:502-505.
39. Padmanabhan M., Prince P.S.M. Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study. Toxicology 2006, 224:128-137.
40. Pan M., Cederbaum A.I., Zhang Y.L., Ginsberg H.N., Williams K.J., Fisher E.A. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 2004, 113:1277-1287.
41. Park S.H., Lee S.G., Kang S.K., Chung S.H. Acanthopanax senticosus reverses fatty liver disease and hyperglycemia in ob/ob mice. Arch. Pharm. Res. 2006, 29:768-776.
42. Patel S.P., Katyare S.S. A comparative study of reactive oxygen species (ros) related parameters in rat tissues. Ind. J. Clin. Biochem. 2006, 21:48-53.
43. Pessayre D., Mansouri A., Fromenty B. Nonalcoholic steatosis and steatohepatitis V Mitochondrial dysfunction in steatohepatitis. Am. J. Physiol. 2002, 282:193-199.
44. Renugadevi, J., Prabu, S.M., 2009. Quercetin protects against oxidative stress-related renal dysfunction by cadmium in rats. Exp Toxicol Pathol. doi:10.1016/j.etp.2009.06.006.
45. Rotruck J.T., Pope A.L., Ganther H., Swanson A.B., Hafeman D.H., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
46. Sung M., Kim I., Park M., Whang Y., Lee M. Differential effects of dietary fatty acids on the regulation of CYP2E1 and protein kinase C in human hepatoma HepG2 cells. J. Med. Food 2004, 7:197-203.
47. Thounaojam M., Jadeja R., Ansarullah, Devkar R., Ramachandran A.V. Dysregulation of lipid and cholesterol metabolism in high fat diet fed hyperlipidemic rats: protective effect of Sida rhomboidea.Roxb leaf extract. J. Health Sci. 2009, 55:413-420.
48. Thounaojam, M.C., Jadeja, R.N., Dandekar, D.S., Devkar, R.V., Ramachandran A.V., 2010a. Sida rhomboidea.Roxb extract alleviates pathophysiological changes in experimental in vivo and in vitro models of high fat diet/fatty acid induced non-alcoholic steatohepatitis. Exp. Toxicol. Pathol. doi:10.1016/j.etp.2010.08.009.
49. Thounaojam, M.C., Jadeja, R.N., Ansarullah., Karn, S.S., Shah, J.D., Patel, D.K., Salunke, S.P., Padate, G.S., Devkar, R.V., Rmachandran A.V., 2010b. Cardioprotective effect of Sida rhomboidea. Roxb extract against isoproterenol induced myocardial necrosis in rats. Exp. Toxicol. Pathol. doi:10.1016/j.etp.2010.02.010.